[1]
|
Mitoma, H., Manto, M. and Hadjivassiliou, M. (2021) Immune-Mediated Cerebellar Ataxias: Clinical Diagnosis and Treatment Based on Immunological and Physiological Mechanisms. Journal of Movement Disorders, 14, 10-28.
https://doi.org/10.14802/jmd.20040
|
[2]
|
Vogrig, A., Gigli, G.L., Segatti, S., et al. (2020) Epidemiology of Para-neoplastic Neurological Syndromes: A Population-Based Study. Journal of Neurology, 267, 26-35. https://doi.org/10.1007/s00415-019-09544-1
|
[3]
|
Waterhouse, D.M., Natale, R.B. and Cody, R.L. (1991) Breast Cancer and Paraneoplastic Cerebellar Degeneration. Cancer, 68, 1835-1841.
https://doi.org/10.1002/1097-0142(19911015)68:8<1835::AID-CNCR2820680833>3.0.CO;2-N
|
[4]
|
Yshii, L., Bost, C. and Liblau, R. (2020) Immunological Bases of Paraneoplastic Cerebellar Degeneration and Therapeutic Implica-tions. Frontiers in Immunology, 11, Article 991. https://doi.org/10.3389/fimmu.2020.00991
|
[5]
|
Manto, M. and Mitoma, H. (2023) Recent Advances in Immune-Mediated Cerebellar Ataxias: Pathogenesis, Diagnostic Approaches, Therapies, and Future Challenges-Editorial. Brain Science, 13, Article 1626.
https://doi.org/10.3390/brainsci13121626
|
[6]
|
Loehrer, P.A., Timmermann, L., Pehl, A., et al. (2020) Rhomben-cephalitis Associated with Isolated Zic4-Antibodies in Paraneoplastic Cerebellar Degeneration: A Case Report. BMC Neurology, 20, Article No. 208.
https://doi.org/10.1186/s12883-020-01788-z
|
[7]
|
Kerber, K.A. (2020) Acute Vestibular Syndrome. Seminars in Neurology, 40, 59-66.
https://doi.org/10.1055/s-0039-3402739
|
[8]
|
Steenerson, K.K. (2021) Acute Vestibular Syndrome. Continuum, 27, 402-419.
https://doi.org/10.1212/CON.0000000000000958
|
[9]
|
Sarikaya, H. and Steinlin, M. (2018) Cerebellar Stroke in Adults and Children. Handbook of Clinical Neurology, 155, 301-312. https://doi.org/10.1016/B978-0-444-64189-2.00020-2
|
[10]
|
Vernino, S. (2012) Paraneoplastic Cerebellar Degenera-tion. Handbook of Clinical Neurology, 103, 215-223.
https://doi.org/10.1016/B978-0-444-51892-7.00013-9
|
[11]
|
Ducray, F., Demarquay, G., Graus, F., et al. (2014) Seronegative Paraneoplastic Cerebellar Degeneration: The PNS Euronetwork Experience. European Journal of Neurolo-gy, 21, 731-735. https://doi.org/10.1111/ene.12368
|
[12]
|
Winklehner, M., Bauer, J., Endmayr, V., et al. (2022) Paraneoplastic Cerebellar Degeneration with P/Q-VGCC vs Yo Autoantibodies. Neurology Neuroimmunology & Neu-roinflammation, 9, e200006.
https://doi.org/10.1212/NXI.0000000000200006
|
[13]
|
Mendes, N.T., Ronchi, N.R. and Silva, G.D. (2022) A Sys-tematic Review on Anti-Yo/PCA-1 Antibody: Beyond Cerebellar Ataxia in Middle-Aged Women with Gynecologic Cancer. The Cerebellum, 22, 1287-1292.
https://doi.org/10.1007/s12311-022-01492-3
|
[14]
|
Greenlee, J.E., Clawson, S.A., Hill, K.E., et al. (2014) Neuronal Uptake of Anti-Hu Antibody, But Not Anti-Ri Antibody, Leads to Cell Death in Brain Slice Cultures. Journal of Neu-roinflammation, 11, Article No. 160.
https://doi.org/10.1186/s12974-014-0160-0
|
[15]
|
Campana, I.G. and Silva, G.D. (2022) Anti-Tr/DNER Anti-body-Associated Cerebellar Ataxia: A Systematic Review. The Cerebellum, 21, 1085-1091. https://doi.org/10.1007/s12311-021-01346-4
|
[16]
|
Mitchell, A.N., Bakhos, C.T. and Zimmerman, E.A. (2015) An-ti-Ri-Associated Paraneoplastic Brainstem Cerebellar Syndrome with Coexisting Limbic Encephalitis in a Patient with Mixed Large Cell Neuroendocrine Lung Carcinoma. Journal of Clinical Neuroscience, 22, 421-423. https://doi.org/10.1016/j.jocn.2014.06.103
|
[17]
|
Madhavan, A.A., Carr, C.M., Morris, P.P., et al. (2020) Imaging Review of Paraneoplastic Neurologic Syndromes. American Journal of Neuroradiology, 41, 2176-2187. https://doi.org/10.3174/ajnr.A6815
|
[18]
|
Hashimoto, Y., Komatsu, K., Nakagawa, T., et al. (2019) Transient Diffu-sion-Weighted Imaging Hyperintensity of the Cerebellar Cortex in Paraneoplastic Cerebellar Degeneration. Internal Med-icine, 58, 619-620.
https://doi.org/10.2169/internalmedicine.1398-18
|
[19]
|
Poudel, C.K. and Achar, K.N. (2013) Gross Cerebellar Paraneoplastic Neurological Disorder in a Patient with an Occult Breast Cancer. BMJ Case Reports, 2013, bcr2012008208. https://doi.org/10.1136/bcr-2012-008208
|
[20]
|
Witt, K.A. and Sandoval, K.E. (2014) Steroids and the Blood-Brain Barrier: Therapeutic Implications. Advances in Pharmacology, 71, 361-390. https://doi.org/10.1016/bs.apha.2014.06.018
|
[21]
|
Shibata, T., Oishi, T., Fukuoka, Y., et al. (2020) Potential Effect of Intravenous Immunoglobulin against Paraneoplastic Cerebellar Degeneration in Progressive Ovarian Cancer. Gyneco-logic Oncology Reports, 34, Article ID: 100649.
https://doi.org/10.1016/j.gore.2020.100649
|
[22]
|
Hu, F.Q., Shang, F.R., Liu, J.J. and Yuan, H. (2020) Plasma Ex-change for Treating Anti-Yo-Associated Paraneoplastic Cerebellar Degeneration: Case Report and Literature Review. Medicine, 99, e21760.
https://doi.org/10.1097/MD.0000000000021760
|